264 related articles for article (PubMed ID: 31631785)
1. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
Chen D; Hou Z; Jiang D; Zheng M; Li G; Zhang Y; Li R; Lin H; Chang J; Zeng H; Guo JT; Zhao X
Emerg Microbes Infect; 2019; 8(1):1511-1523. PubMed ID: 31631785
[TBL] [Abstract][Full Text] [Related]
2. Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).
Zhou N; Pan T; Zhang J; Li Q; Zhang X; Bai C; Huang F; Peng T; Zhang J; Liu C; Tao L; Zhang H
J Biol Chem; 2016 Apr; 291(17):9218-32. PubMed ID: 26953343
[TBL] [Abstract][Full Text] [Related]
3. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
4. Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.
Lay Mendoza MF; Acciani MD; Levit CN; Santa Maria C; Brindley MA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33348746
[TBL] [Abstract][Full Text] [Related]
5. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
[TBL] [Abstract][Full Text] [Related]
6. Emerging intracellular receptors for hemorrhagic fever viruses.
Jae LT; Brummelkamp TR
Trends Microbiol; 2015 Jul; 23(7):392-400. PubMed ID: 26004032
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
[TBL] [Abstract][Full Text] [Related]
8. Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples.
Matranga CB; Andersen KG; Winnicki S; Busby M; Gladden AD; Tewhey R; Stremlau M; Berlin A; Gire SK; England E; Moses LM; Mikkelsen TS; Odia I; Ehiane PE; Folarin O; Goba A; Kahn SH; Grant DS; Honko A; Hensley L; Happi C; Garry RF; Malboeuf CM; Birren BW; Gnirke A; Levin JZ; Sabeti PC
Genome Biol; 2014; 15(11):519. PubMed ID: 25403361
[TBL] [Abstract][Full Text] [Related]
9. 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.
Shrivastava-Ranjan P; Bergeron É; Chakrabarti AK; Albariño CG; Flint M; Nichol ST; Spiropoulou CF
mBio; 2016 Dec; 7(6):. PubMed ID: 27999160
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM
Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
[TBL] [Abstract][Full Text] [Related]
11. Immunobiology of Ebola and Lassa virus infections.
Prescott JB; Marzi A; Safronetz D; Robertson SJ; Feldmann H; Best SM
Nat Rev Immunol; 2017 Mar; 17(3):195-207. PubMed ID: 28111475
[TBL] [Abstract][Full Text] [Related]
12. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.
Gnirss K; Kühl A; Karsten C; Glowacka I; Bertram S; Kaup F; Hofmann H; Pöhlmann S
Virology; 2012 Mar; 424(1):3-10. PubMed ID: 22222211
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
14. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
[TBL] [Abstract][Full Text] [Related]
15. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.
Andersen KG; Shapiro BJ; Matranga CB; Sealfon R; Lin AE; Moses LM; Folarin OA; Goba A; Odia I; Ehiane PE; Momoh M; England EM; Winnicki S; Branco LM; Gire SK; Phelan E; Tariyal R; Tewhey R; Omoniwa O; Fullah M; Fonnie R; Fonnie M; Kanneh L; Jalloh S; Gbakie M; Saffa S; Karbo K; Gladden AD; Qu J; Stremlau M; Nekoui M; Finucane HK; Tabrizi S; Vitti JJ; Birren B; Fitzgerald M; McCowan C; Ireland A; Berlin AM; Bochicchio J; Tazon-Vega B; Lennon NJ; Ryan EM; Bjornson Z; Milner DA; Lukens AK; Broodie N; Rowland M; Heinrich M; Akdag M; Schieffelin JS; Levy D; Akpan H; Bausch DG; Rubins K; McCormick JB; Lander ES; Günther S; Hensley L; Okogbenin S; ; Schaffner SF; Okokhere PO; Khan SH; Grant DS; Akpede GO; Asogun DA; Gnirke A; Levin JZ; Happi CT; Garry RF; Sabeti PC
Cell; 2015 Aug; 162(4):738-50. PubMed ID: 26276630
[TBL] [Abstract][Full Text] [Related]
16. Virus entry. Lassa virus entry requires a trigger-induced receptor switch.
Jae LT; Raaben M; Herbert AS; Kuehne AI; Wirchnianski AS; Soh TK; Stubbs SH; Janssen H; Damme M; Saftig P; Whelan SP; Dye JM; Brummelkamp TR
Science; 2014 Jun; 344(6191):1506-10. PubMed ID: 24970085
[TBL] [Abstract][Full Text] [Related]
17. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
Mittler E; Alkutkar T; Jangra RK; Chandran K
mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
[TBL] [Abstract][Full Text] [Related]
18. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
19. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
mBio; 2018 May; 9(3):. PubMed ID: 29717011
[TBL] [Abstract][Full Text] [Related]
20. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
